ArticleCellular oncology (Dordrecht, Netherlands)2026

USP10 confers lenvatinib resistance in hepatocellular carcinoma by deubiquitinating the GPX2.

Cheng-Rui Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.